600725-11-9

Basic information

• Product Name: 1,2-Benzenediamine, N-[4-(dimethylamino)butyl]-
• CAS NO: 600725-11-9
• Molecular Formula: C12H21N3
• Molecular Weight: 207.319
• Mol File: 600725-11-9.mol

Chemical Properties

• CAS DataBase Reference: 1,2-Benzenediamine, N-[4-(dimethylamino)butyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-Benzenediamine, N-[4-(dimethylamino)butyl]-(600725-11-9)
• EPA Substance Registry System: 1,2-Benzenediamine, N-[4-(dimethylamino)butyl]-(600725-11-9)

Safety Data

• Hazardous Substances Data: 600725-11-9(Hazardous Substances Data)

Upstream product

• 1493-27-2 ortho-nitrofluorobenzene 
• 3529-10-0 4-(Dimethylamino)butylamine 

Downstream Products

• 600724-70-7 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carboxylic acid {2-(3,4-diethyl-phenyl)-1-[1-(4-dimethylamino-butyl)-1H-benzimidazol-2-yl]-ethyl}-amide 

Relevant articles and documents

Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[ a[phenazin derivatives as dual topoisomerase I/II inhibitors

A novel series of benzo[a]phenazin derivatives bearing alkylamino side chains were designed, synthesized and evaluated for their topoisomerases inhibitory activity as well as cytotoxicity against four human cancer cell lines (HL-60, K-562, HeLa, and A549)

Novel substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof

The present invention relates to substituted piperidines of general formula wherein R, R2 to R5, A, X, Z and n are defined as in claim 1, the tautomers, diastereomers, enantiomers, mixtures and salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases which have valuable pharmacological properties, particularly CGRP-antagonistic properties, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof.